Checking and evaluation of CReSA’s portfolio will be financed by Acc1Ó with the purpose of valorizing the knowledge stock accumulated in the center with commercial possibilities.

CReSA centralizes its activity in the facilities of the CReSA building, which incorporates a wide technological offer with capability for virological, immunological, molecular biology and microbiological studies, and constitutes a reference centre for research and giving support to administrations, as well as to other institutions and companies.

Exhaustive analyses of the knowledge will allow detecting technologies or knowledge with possibilities to be introduced into the animal health market. Knowledge will be valorized by KIMbcn.